MAPT and Alzheimer disease: This may also suggest the significance of tau PET as a predictor of the following neurodegenerative processes, resembling findings in patients with AD, who show a tight correlation between baseline retention of a tau PET probe and subsequent longitudinal atrophy of the cortex.25